Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort
Keywords: 
All-cause mortality
Chest CT
Comorbidity
COPD
Tomography
Issue Date: 
2022
Publisher: 
Wiley
ISSN: 
1440-1843
Note: 
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License
Citation: 
Ezponda, A. (Ana); Casanova, C. (Ciro); Divo, M. (Miguel); et al. "Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort". Respirology. (27), 2022, 286 - 293
Abstract
Abstract Background and objective: The availability of chest computed tomography (CT) imaging can help diagnose comorbidities associated with chronic obstructive pulmonary disease (COPD). Their systematic identification and relationship with allcause mortality have not been explored. Furthermore, whether their CT-detected prevalence differs from clinical diagnosis is unknown. Methods: The prevalence of 10 CT-assessed comorbidities was retrospectively determined at baseline in 379 patients (71% men) with mild to severe COPD attending pulmonary clinics. Anthropometrics, smoking history, dyspnoea, lung function, exercise capacity, BODE (BMI, Obstruction, Dyspnoea and Exercise capacity) index and exacerbations rate were recorded. The prevalence of CT-determined comorbidities was compared with that recorded clinically. Over a median of 78 months of observation, the independent association with all-cause mortality was analysed. A ‘CT-comorbidome’ graphically expressed the strength of their association with mortality risk. Results: Coronary artery calcification, emphysema and bronchiectasis were the most prevalent comorbidities (79.8%, 62.7% and 33.9%, respectively). All were underdiagnosed before CT. Coronary artery calcium (hazard ratio [HR] 2.09; 95% CI 1.03–4.26, p = 0.042), bronchiectasis (HR 2.12; 95% CI 1.05–4.26, p = 0.036) and low psoas muscle density (HR 2.61; 95% CI 1.23–5.57, p = 0.010) were independently associated with all-cause mortality and helped define the ‘CT-comorbidome’. Conclusion: This study of COPD patients shows that systematic detection of 10 CT-diagnosed comorbidities, most of which were not detected clinically, provides information of potential use to patients and clinicians caring for them.

Files in This Item:
Thumbnail
File
Respirology - 2022 - Ezponda - Chest CT‐assessed comorbidities and all‐cause mortality risk in COPD patients in the BODE.pdf
Description
Size
3.69 MB
Format
Adobe PDF


Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.